Serialisation ,e-labelling and counterfeit avoidance.

SignaKey CEO Richard McDermott presented at the 6th Annual Pharma Anti-Counterfeiting & Serialisation 2017 conference on 19th & 20th September 2017, at the Pestana Chelsea Bridge Hotel, London, UK.
The Counterfeiting of drugs & medicines is a $200 billion industry. SignaKey's authentication & verification solution utilises a secure data base & offers a unique serialisation solution. The technology enables verification checks throughout the supply chain - from the Manufacturing location to the Consumer and the data is accessible from a smart phone App.
SignaKey is used across a number of applications and industries which includes electronics, pharma, automotive and security.
For more information please contact Richard McDermott on Rmcd@SignaKey.com
Comments